232 related articles for article (PubMed ID: 7577742)
21. The S-phase fraction of the aneuploid cell subpopulation is the biologically relevant one in aneuploid breast cancers.
Martinez-Arribas F; Nuñez-Villar MJ; Lucas AR; Sanchez J; Tejerina A; Schneider J
Breast Cancer Res Treat; 2005 Jul; 92(1):77-80. PubMed ID: 15980994
[TBL] [Abstract][Full Text] [Related]
22. [Assay of DNA content and estrogen receptor status in human breast cancer].
Chen GJ; Shao YF; Shan Y
Zhonghua Zhong Liu Za Zhi; 1994 Nov; 16(6):461-4. PubMed ID: 7720507
[TBL] [Abstract][Full Text] [Related]
23. Flow cytometric DNA content of fresh tumor specimens using keratin-antibody as second stain for two-parameter analysis.
van der Linden JC; Herman CJ; Boenders JG; van de Sandt MM; Lindeman J
Cytometry; 1992; 13(2):163-8. PubMed ID: 1372209
[TBL] [Abstract][Full Text] [Related]
24. DNA aneuploidy and proliferation in spontaneous human and dimethylhydrazine-induced murine colorectal carcinogenesis.
Fischbach W; Rübsam B; Mössner J; Wünsch HP; Seyschab H; Höhn H
Z Gastroenterol; 1991 Oct; 29(10):533-7. PubMed ID: 1781191
[TBL] [Abstract][Full Text] [Related]
25. Comparison of flow cytometric DNA content analysis of fresh and formalin-fixed paraffin-embedded solid neoplasms.
Kumar D; Kumar S; Lyon D
Mod Pathol; 1994 Apr; 7(3):354-60. PubMed ID: 8058708
[TBL] [Abstract][Full Text] [Related]
26. Flow cytometry in primary breast carcinomas: prognostic impact of S-phase fraction according to different analysis patterns.
Michels JJ; Marnay J; Plancoulaine B; Chasle J
Cytometry B Clin Cytom; 2004 May; 59(1):32-9. PubMed ID: 15108168
[TBL] [Abstract][Full Text] [Related]
27. [Preliminary study by flow cytometry of the cell cycle and DNA quantification in cytokeratin-positive cells in tumors of the head and neck].
Górriz C; González FM; Castejón R; García-Berrocal JR; Durántez A; Vargas JA
Acta Otorrinolaringol Esp; 1999 May; 50(4):296-304. PubMed ID: 10431079
[TBL] [Abstract][Full Text] [Related]
28. Two-color multiparametric method for flow cytometric DNA analysis of carcinomas using staining for cytokeratin and leukocyte-common antigen.
Zarbo RJ; Visscher DW; Crissman JD
Anal Quant Cytol Histol; 1989 Dec; 11(6):391-402. PubMed ID: 2481453
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of DNA ploidy status in patients with rectal cancer.
Berczi C; Bocsi J; Bartha I; Math J; Balazs G
Anticancer Res; 2002; 22(6B):3737-41. PubMed ID: 12552986
[TBL] [Abstract][Full Text] [Related]
30. Image and flow cytometric analysis of DNA content in breast cancer. Relation to estrogen receptor content and lymph node involvement.
Cornelisse CJ; de Koning HR; Moolenaar AJ; van de Velde CJ; Ploem JS
Anal Quant Cytol; 1984 Mar; 6(1):9-18. PubMed ID: 6732072
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of a modeling system for S-phase estimation in breast cancer by flow cytometry.
Dressler LG; Seamer L; Owens MA; Clark GM; McGuire WL
Cancer Res; 1987 Oct; 47(20):5294-302. PubMed ID: 3652035
[TBL] [Abstract][Full Text] [Related]
32. DNA ploidy analysis and cytologic examination of sorted cell populations from human breast tumors.
Cornelisse CJ; Tanke HJ; de Koning H; de la Riviere GB
Anal Quant Cytol; 1983 Sep; 5(3):173-83. PubMed ID: 6651016
[TBL] [Abstract][Full Text] [Related]
33. Flow cytometric DNA analysis of breast cancer by two colour method using cytokeratin labeling for identification of tumour cells.
Kimmig R; Spelsberg H; Kapsner T; Untch M; Hepp H
Anal Cell Pathol; 1994 Oct; 7(3):205-15. PubMed ID: 7531483
[TBL] [Abstract][Full Text] [Related]
34. Proliferative characteristics and ploidy of human brain tumors by DNA flow cytometry.
Danova M; Riccardi A; Mazzini G; Ucci G; Montecucco CM; Gaetani P; Silvani V; Knerich R; Butti G; Ascari E
Basic Appl Histochem; 1986; 30(2):175-80. PubMed ID: 3741314
[TBL] [Abstract][Full Text] [Related]
35. DNA aneuploidy in Hodgkin's disease. A multiparameter flow-cytometric analysis with cytologic correlation.
Anastasi J; Bauer KD; Variakojis D
Am J Pathol; 1987 Sep; 128(3):573-82. PubMed ID: 3307446
[TBL] [Abstract][Full Text] [Related]
36. Flow cytometric measurement of DNA content in human solid tumors: a comparison with cytogenetics.
Rapi S; Caldini A; Fanelli A; Berti P; Lisi E; Anichini E; Caligiani R; Sbernini F; Taddei G; Amorosi A; Villari D; Susini T
Cytometry; 1996 Sep; 26(3):192-7. PubMed ID: 8889390
[TBL] [Abstract][Full Text] [Related]
37. Heterogeneity of DNA ploidy in gastric cancer.
Yonemura Y; Matsumoto H; Ninomiya I; Ohoyama S; Kimura H; de Aletxabala X; Sugiyama K; Kamata T; Kinoshita K; Fushida S
Anal Cell Pathol; 1992 Mar; 4(2):61-7. PubMed ID: 1550795
[TBL] [Abstract][Full Text] [Related]
38. Testicular seminomas are aneuploid tumors.
Hittmair A; Rogatsch H; Feichtinger H; Hobisch A; Mikuz G
Lab Invest; 1995 Jan; 72(1):70-4. PubMed ID: 7837793
[TBL] [Abstract][Full Text] [Related]
39. Androgen and vitamin D receptor expression in archival human breast tumors.
Krishan A; Arya P; Ganjei-Azar P; Shirley SE; Escoffery CT; Nadji M
Cytometry B Clin Cytom; 2004 Mar; 58(1):53-60. PubMed ID: 14994376
[TBL] [Abstract][Full Text] [Related]
40. DNA ploidy and proliferation heterogeneity in human prostate cancers.
Shankey TV; Jin JK; Dougherty S; Flanigan RC; Graham S; Pyle JM
Cytometry; 1995 Sep; 21(1):30-9. PubMed ID: 8529468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
